Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States
Open Access
- 17 June 2014
- journal article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 10 (8) , 2255-2266
Abstract
This study aims to quantify clinical and economic burden of rotavirus (RV) infection pre- and post-vaccine introduction in commercially insured and Medicaid populations. Beneficiaries with continuous enrollment for ≥6 months while <5 years of age were identified separately in commercial (2000–2010) and Medicaid (2002–2009) claims databases. Commercial and Medicaid databases included 3 998 708 and 1 034 440 eligible children, respectively, observed from enrollment start date(s) to end of eligibility or 5-years-old. Rates of RV-coded and diarrhea-coded encounters and first RV episodes, and incremental cost of first RV episodes were calculated. In the post-vaccine period, rates per 10 000 person-years for RV-coded hospitalizations, outpatient visits and ER visits were 5.58 (95% CI, 5.37–5.80), 6.96 (95% CI, 6.75–7.20), and 4.85 (95% CI, 4.66–5.06), respectively (pre-vaccine, 16.67 [95% CI, 16.19–17.15], 13.20 [95% CI, 12.78–13.63], 11.26 [95% CI, 10.87–11.66], respectively), for commercially insured. In Medi...Keywords
This publication has 27 references indexed in Scilit:
- Rotavirus vaccines. WHO position paper – January 2013.2013
- Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).2009
- Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007.2008
- Cost-effectiveness and Potential Impact of Rotavirus Vaccination in the United StatesPediatrics, 2007
- Diarrhea- and Rotavirus-Associated Hospitalizations Among Children Less Than 5 Years of Age: United States, 1997 and 2000Pediatrics, 2006
- Hospitalizations Associated With Rotavirus Gastroenteritis in the United States, 1993–2002The Pediatric Infectious Disease Journal, 2006
- TEMPORAL AND GEOGRAPHIC TRENDS OF ROTAVIRUS ACTIVITY IN THE UNITED STATES, 1997–2004The Pediatric Infectious Disease Journal, 2006
- Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus VaccineNew England Journal of Medicine, 2006
- Cost-effectiveness Analysis of a Rotavirus Immunization Program for the United StatesJAMA, 1998
- Hospitalizations Associated with Rotavirus Diarrhea in the United States, 1993 through 1995: Surveillance Based on the New ICD‐9‐CM Rotavirus‐Specific Diagnostic CodeThe Journal of Infectious Diseases, 1998